Persistent Depressive Disorder (Dysthymia)

Risk factors

• Family history of depressive disorders
• Early-life adversity, childhood trauma or neglect
• Female sex
• Chronic medical illness, chronic stressors
• Comorbid anxiety or substance use disorder
• Personality traits: high neuroticism, low extraversion

Pathophysiology

Multifactorial: dysregulation of monoaminergic (serotonin, norepinephrine, dopamine) neurotransmission, HPA axis hyperactivity, reduced hippocampal volume, neuroinflammation, and gene-environment interactions (e.g., serotonin transporter polymorphisms with early adversity).

Clinical presentation

Differential diagnosis

• Major depressive disorder — Discrete episodes ≥2 weeks with more severe symptom count; PDD is chronic and lower-grade — the two may coexist ('double depression')
• Bipolar II disorder — History of hypomanic episodes interspersed with depressive symptoms — always screen for past hypomania before starting an antidepressant
• Cyclothymic disorder — Chronic mood instability with hypomanic and depressive symptoms not meeting full episode criteria
• Adjustment disorder with depressed mood — Identifiable stressor within 3 months, symptoms resolve within 6 months of stressor ending
• Hypothyroidism — Fatigue, weight gain, cold intolerance, bradycardia, elevated TSH — always check TSH in chronic low mood
• Substance/medication-induced depression — Alcohol, sedatives, interferon, glucocorticoids, beta-blockers; temporal link to use
• Anemia, vitamin B12 or D deficiency, OSA — Fatigue and cognitive slowing mimicking depression; targeted labs and sleep history

Diagnostic workup

Diagnostic algorithm

flowchart TD
  A[Chronic low mood] --> B{Duration ≥2 yr<br/>adults / ≥1 yr youth?}
  B -->|No| C[Consider MDD<br/>or adjustment d/o]
  B -->|Yes| D{≥2 associated<br/>symptoms?}
  D -->|No| E[Subthreshold —<br/>monitor + support]
  D -->|Yes| F{Symptom-free<br/>>2 mo at any time?}
  F -->|Yes| C
  F -->|No| G{History of mania<br/>or hypomania?}
  G -->|Yes| H[Bipolar spectrum —<br/>do NOT give SSRI alone]
  G -->|No| I[Persistent Depressive Disorder]
  I --> J[SSRI/SNRI + CBT/CBASP/IPT]
  J --> K[Reassess at 8-12 wk]

Treatment

Complications

• Superimposed MDD episodes ('double depression') — higher suicide risk than either alone
• Substance use disorders
• Occupational and relational impairment over decades
• Increased medical comorbidity (cardiovascular disease, diabetes)
• Suicide — screen at every visit

PANCE pearls

• Always screen for past hypomania before starting an antidepressant — missing bipolarity is a common pitfall in chronic low mood.
• TSH and B12 are required-of-the-board labs in any new depression workup.
• CBASP is the only psychotherapy designed specifically for chronic depression and outperforms generic CBT in some trials.
• Treatment response in PDD is often slower (12-16 weeks) than in MDD — do not abandon a trial prematurely.
• Children and adolescents need only 1 year of symptoms and may present with irritability rather than sadness.

References

• DSM-5-TR — American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). 2022.
• APA 2010 — American Psychiatric Association Practice Guideline for the Treatment of Patients with Major Depressive Disorder, 3rd ed. 2010 (reaffirmed).
• USPSTF 2023 — US Preventive Services Task Force. Screening for Depression and Suicide Risk in Adults. JAMA 2023;329(23):2057-2067.